GlassScriptPhysician profile
Michael R Kaufman
NPI 1669887303
$3,300.51
in general payments reported to CMS, 2019-2025
24 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $98.69 · 2021: $436 · 2022: $778 · 2023: $348 · 2024: $391 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,232.84 | 2022-2025 | Inspire |
| Stryker Corporation | $503.16 | 2019-2022 | |
| Cochlear Americas | $246.00 | 2020-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Cumberland Pharmaceuticals, INC. | $236.08 | 2022-2024 | Caldolor |
| Regeneron Healthcare Solutions, INC. | $190.69 | 2022-2025 | Dupixent |
| Advanced Bionics, LLC | $178.31 | 2022-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Genzyme Corporation | $154.30 | 2019-2025 | |
| Medtronic, INC. | $112.55 | 2021-2024 | Sinuva |
| Astrazeneca Pharmaceuticals LP | $111.29 | 2025 | Tezspire |
| Amgen INC. | $51.74 | 2025 | Tezspire |
| Intersect Ent, INC. | $47.59 | 2020-2022 | |
| Optinose US, INC. | $32.47 | 2020-2022 | |
| Glaxosmithkline, LLC. | $30.38 | 2021-2024 | Nucala |
| Checkpoint Surgical, INC | $22.33 | 2021 | |
| Med-El Corporation | $20.67 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $18.18 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.50 | 2022 | |
| Baxter Healthcare | $16.50 | 2022 | |
| Aerin Medical INC. | $15.54 | 2019 | |
| Acclarent, INC | $14.02 | 2019 | |
| Merck Sharp & Dohme LLC | $13.62 | 2023 | |
| Axogen | $12.06 | 2019 | |
| Smith+Nephew, INC. | $11.56 | 2019 | |
| Olympus America INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.